Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma

Koopmans, J. G.; Lulfer, R.; Jansen, H. M.; Van Der Zee, J. S.
April 2006
Thorax;Apr2006, Vol. 61 Issue 4, p306
Academic Journal
Background: Addition of the long acting β2 agonist salmeterol to inhaled corticosteroids leads to better symptomatic asthma control than increasing the dose of inhaled corticosteroids. However, little is known about the long term effects of adding salmeterol on the asthmatic inflammatory process, control of which is considered important for the long term outcome of asthma. Methods: After a 4 week fluticasone run-in period, 54 patients with allergic asthma were randomised to receive twice daily treatment with fluticasone 250 µg with or without salmeterol 50 µg for 1 year in a double blind, parallel group design (total daily dose of fluticasone 500 µin both treatment groups). Primary outcomes were sputum eosinophil numbers and eosinophil cationic protein concentrations. Secondary outcomes were neutrophil associated sputum parameters and a respiratory membrane permeability marker. The effects on allergen induced changes were determined before and at the end of the treatment period. Results: Adding salmeterol to fluticasone resulted in improved peak expiratory flow, symptom scores, rescue medication usage, and bronchial hyperresponsiveness (p<0.05 for all). There was no sustained effect on sputum cell differential counts and cytokine concentrations during the treatment period or on changes induced by allergen challenge at the end of treatment (p>0.05). However, adding salmeterol significantly reduced sputum ratios of α2-macroglobulin and albumin during the treatment period (p=0.001). Conclusions: The addition of salmeterol to fluticasone produces no sustained effect on allergen induced cellular bronchial inflammation but leads to a significant improvement in size selectivity of plasma protein permeation across the respiratory membrane. This may contribute to the improved clinical outcome seen in patients with allergic asthma when a long acting β2 agonist is combined with inhaled corticosteroids.


Related Articles

  • Anti-Inflammatory Activities of α2-Agonists. Hanania, Nicola A.; Moore, Robert H. // Current Drug Targets - Inflammation & Allergy;Sep2004, Vol. 3 Issue 3, p271 

    Beta2-adrenergic agonists ( β2-agonists) play a pivotal role in the acute and chronic management of asthma. Their major action on the airways is the relaxation of smooth muscle cells. In addition to their bronchodilator properties, β2-agonists may have other effects through their...

  • Considerations in the long-term management of asthma in ambulatory patients. Williams, Dennis M. // American Journal of Health-System Pharmacy;5/15/2006, Vol. 63 Issue 10, pS14 

    Purpose. The goals of treatment and drug therapies used for long-term asthma control, classification of the disease by severity, and treatment based on severity are reviewed, with an emphasis on recent controversies in treatment approach and safety concerns. Summary. Patient education and...

  • Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Van Steenis, M. N. A.; Driesenaar, J. A.; Bensing, J. M.; Van Hulten, R.; Souverein, P. C.; Van Dijk, L.; De Smet, P. A. G. M.; Van Dulmen, A. M. // Patient Preference & Adherence;2014, Vol. 8, p83 

    Background: Beliefs play a crucial role in medication adherence. Interestingly, the relationship between beliefs and adherence varies when different adherence measures are used. How adherence, in turn, is related to asthma symptoms is still unclear. Our aim was to investigate the relationship...

  • Doubling Steroids Does Not Stop Asthma Exacerbations. Walling, Anne D. // American Family Physician;9/15/2004, Vol. 70 Issue 6, p1161 

    Discusses the study "Doubling the Dose of Inhaled Corticosteroid to Prevent Asthma Exacerbations: Randomised Controlled Trial," by T. W. Harrison et al., published in the January 24, 2004 issue of the journal "The Lancet." Study subjects; Treatments given; Intepretation of the research findings.

  • Pharmacotherapy -- add-on therapies.  // CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS37 

    The article focuses on the effectiveness regarding the use inhaled corticosteriods (ICS)and leukotriene receptor antagonists (LTRA)as add-on therapy in treating children with asthma. The effectiveness ICS has been compared with long-acting bronchodilators (LABA) such as salmenterol or...

  • Novel Strategies for the Treatment of Asthma. Takizawa, Hajime // Recent Patents on Inflammation & Allergy Drug Discovery;Feb2007, Vol. 1 Issue 1, p13 

    It is now clear that airway inflammatory processes characterized by eosinophils and Th2 lymphocytes are pivotal as the pathological features of asthma. Standard inhaled corticosteroids markedly suppress such inflammatory changes, resulting in clinical beneficial effects. However, it is also...

  • Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils. Bit Na Kang; Sung Gil Ha; Bahaie, Nooshin S.; Hosseinkhani, M. Reza; Xiao Na Ge; Blumenthal, Malcolm N.; Rao, Savita P.; Sriramarao, P. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Association of the neurotransmitter serotonin (5-HT) with the pathogenesis of allergic asthma is well recognized and its role as a chemoattractant for eosinophils (Eos) in vitro and in vivo has been previously demonstrated. Here we have examined the regulation of 5-HT-induced human and murine...

  • Does blood eosinophilia in wheezing infants predict later asthma? A prospective 18—20-year follow-up. Piippo-Savolainen, Eija; Remes, Sami; Korppi, Matti // Allergy & Asthma Proceedings;Mar/Apr2007, Vol. 28 Issue 2, p163 

    Although eosinophilia in wheezing infants predicts subsequent wheezing, it is not known how long the association persists. Our aim was to evaluate the connection between blood eosinophilia in infancy and later wheezing/asthma until adulthood, with special attention paid to infection-induced...

  • Eosinophilic esophagitis: Review of nonsurgical treatment modalities. Reddy, Vinitha; Ghaffari, Gisoo // Allergy & Asthma Proceedings;Sep/Oct2013, Vol. 34 Issue 5, p421 

    Eosinophilic esophagitis (EoE) is a clinicopathological condition characterized by the combination of upper gastrointestinal symptoms such as dysphagia and even food impaction in association with histological findings of >15 eosinophils/high-powered field found in endoscopic biopsy specimens....


Read the Article


Sign out of this library

Other Topics